ARTRYA
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease. Left undiagnosed, patients remain at risk, incorrect treatment regimes are administered and cost burdens on health systems escalate. With ageing populations and the demand for medical services rising globally, significant delays in reporting can leave patients in critical situations.
ARTRYA
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Health Diagnostics Machine Learning Medical Software
Founded:
2019-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.artrya.com
Total Employee:
11+
Status:
Active
Total Funding:
15 M USD
Technology used in webpage:
Domain Not Resolving Font Awesome IPv6 Nginx Cloudflare JS CDN JS AJAX Libraries API U.S. Server Location Ruby On Rails Token Typekit
Similar Organizations
Basecamp Research
Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products
Brainomix
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
DeepCure
DeepCuris builds an AI engine for small-molecule drug discovery.
Delfi Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Oscer
Oscer is a clinical training that offers advanced machine learning and artificial intelligence service.
Overjet
Overjet combines deep learning of dental images and data science to empower dental providers and payers to deliver the best patient care.
SeedBlink
SeedBlink is Europe’s fastest growing investing platform specialized in sourcing, vetting, financing and scaling tech start-ups.
Sema4
Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Septerna
Septerna is a biotechnology company.
Current Employees Featured
Girish Dwivedi Chief Medical Officer @ Artrya
Chief Medical Officer
Jessica Monk Chief Marketing Officer @ Artrya
Chief Marketing Officer
2021-06-01
Julien Flack Chief Technology Officer @ Artrya
Chief Technology Officer
2019-06-01
John Barrington Co-Founder & Managing Director @ Artrya
Co-Founder & Managing Director
2018-01-01
Mark Wainwright CFO @ Artrya
CFO
John Konstantopoulos Co-Founder & Executive Director @ Artrya
Co-Founder & Executive Director
2018-01-01
Janice Marcon Chief People & Culture Officer @ Artrya
Chief People & Culture Officer
2021-07-01
Founder
Stock Details
Investors List
Watermark Funds Management
Watermark Funds Management investment in Series A - Artrya
Washington H. Soul Pattinson
Washington H. Soul Pattinson investment in Series A - Artrya
Thorney Investment
Thorney Investment investment in Series A - Artrya
Regal Funds Management
Regal Funds Management investment in Series A - Artrya
Official Site Inspections
http://www.artrya.com Semrush global rank: 11.48 M Semrush visits lastest month: 159
- Host name: artrya.tempurl.host
- IP address: 67.219.104.57
- Location: West Chester United States
- Latitude: 39.9444
- Longitude: -75.5875
- Metro Code: 504
- Timezone: America/New_York
- Postal: 19382
More informations about "Artrya"
Artrya - Crunchbase Company Profile & Funding
Organization. Artrya . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Artrya uses artificial intelligence to deliver …See details»
Artrya | AI-Driven Healthcare Tech Company
Artrya partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation …See details»
Who We Are - Artrya
Artrya is an AI-driven MedTech company, founded in 2019, and brought to life in Perth, Australia. Artrya was co-founded by John Konstantopoulos and John Barrington AM, who came together …See details»
Investor Relations | Artrya
Company Details. Name: Artrya Limited Incorporated: ACN 624 005 741 Business description: AI-based coronary artery disease Diagnostic support software Registered office: 1257 Hay St …See details»
Artrya Company Profile - Office Locations, Competitors, Revenue …
Oct 16, 2024 Artrya. Stock Price. $0.3. 2024-10-16. Artrya Summary. Company Summary. Overview. Artrya is an artificial intelligence healthcare company. It offers cloud software, …See details»
Artrya Company Profile 2025: Stock Performance & Earnings
Artrya General Information Description. Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence …See details»
Artrya Ltd Overview | SignalHire Company Profile
Artrya Ltd Overview ... Organization Website. artrya.com . Contact Email [email protected] Artrya Ltd industries. Medtech Headquarters Location. Perth, Western Australia, 6000 AU. Artrya Ltd …See details»
Artrya - Overview, News & Similar companies | ZoomInfo.com
Apr 2, 2023 View Artrya (www.artrya.com) location in Western Australia, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Artrya Limited (ASX: AYA) Company Profile & Overview - Stock …
Nov 1, 2024 Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address …See details»
Artrya - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 29, 2024 Organization. Artrya . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 62. Monthly …See details»
BOARD AND MANAGEMENT CHANGES For personal use only
Mar 27, 2023 Artrya Limited +61 419 386 312 . investors@artrya.com About Artrya . Based in Perth, Australia, Artrya was founded in 2018 and commenced operations in early 2019. Artrya …See details»
ARTRYA LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARTRYA LIMITED of West Perth, WESTERN AUSTRALIA. Get the latest business insights from Dun & …See details»
Artrya - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 25, 2021: Series A - …See details»
Artrya - Company Profile - Tracxn
Oct 16, 2024 Artrya gets to the heart of AI with ASX listing, $40 million IPOProactive • Nov 26, 2021 • Artrya AI medical technology start-up Artrya looking to list TechInvest • Oct 19, 2021 • …See details»
Artrya - Contacts, Employees, Board Members, Advisors & Alumni
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.See details»
The rise of artificial intelligence in healthcare - Artrya
Website: www.artrya.com Company Synopsis: Artrya Ltd (ASX:AYA) is an AI-driven health-tech company focused on disrupting how coronary artery disease is diagnosed. …See details»
Leadership Team - Artrya
As Artrya’s Chief Scientific Officer, Professor Girish Dwivedi, MD is excited to be working within the MedTech industry to innovate and create solutions using advanced technology, such as …See details»
Artrya Opens US Operations in California
ASX Announcement 29th March 2022. Perth, Western Australia – Australian medical technology company, Artrya Limited (ASX: AYA, Artrya or the Company) creator of the AI-based solution, …See details»
Company News - Artrya
Aug 25, 2022 Artrya's newsroom is the hub for all news and updates pertaining to Artrya. Our solution. Knowledge hub. About Artrya. Investor Relations. Contact Us Request a …See details»
Careers - Artrya
Artrya is a collaborative work environment, with brainstorming and problem solving happening constantly between all team members. Often, a conversation will strike up involvement from …See details»